Results 31 to 40 of about 14,372 (207)

Infertility after long-acting paliperidone palmitate treatment: A case report (tur)

open access: yesKlinik Psikiyatri Dergisi, 2020
Hyperprolactinemia is a common side effect of antipsychotic treatments. Conventional antipsychotics increase prolactin secretion due to their strong D2 receptor antagonism and long-term dependence on the receptor.
Kerim Uğur, Sevler Yıldız
doaj   +1 more source

The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients

open access: yesKaohsiung Journal of Medical Sciences, 2012
This study investigated the differences in clinical and laboratory features as well as treatment response in 70 outpatients with macroprolactinemia and monomeric hyperprolactinemia treated with dopamine agonists.
Chih-Chin Lu, Ching-Jung Hsieh
doaj   +1 more source

Can Aripiprazole Normalize Yatrogenic Hyperprolactinemia?

open access: yes, 2023
Aripiprazole is a second generation atypical antipsychotic (AAP), with properties of partial dopamine agonist, used in schizophrenia, bipolar disorder and depression, among others.
Roberto Lozano   +3 more
core   +1 more source

Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? [PDF]

open access: yesРМЖ. Мать и дитя, 2020
Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? A.A. Olina D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction, St.
A.A. Olina
doaj  

Depression, anxiety, sexual function and quality of life in women with hyperprolactinemia [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia
Objective: To evaluate anxiety, depression, sexual function and quality of life in women with hyperprolactinemia. Methods: Cross-sectional study with 80 women divided into two groups: 30 women with hyperprolactinemia (Study Group) followed and treated ...
Renan Massao Nakamura   +7 more
doaj   +1 more source

Diagnostic subcategories and hyperprolactinemia.

open access: yes, 2020
Diagnostic subcategories and hyperprolactinemia.
Sorin Ursoniu (661005)   +6 more
core   +1 more source

Mild hyperprolactinemia in women with polycystic ovary syndrome. Insights from a large cross-sectional study

open access: yesJournal of Clinical & Translational Endocrinology
Background: Hyperprolactinemia is an exclusion criterion for polycystic ovary syndrome (PCOS), albeit PCOS itself is argued to induce mild hyperprolactinemia.
Manuel Luque-Ramírez   +6 more
doaj   +1 more source

Correlation of anthropometric parameters with serum progesterone levels for the prediction of ovulation in infertile women in Ile‐Ife, Nigeria

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To correlate anthropometric parameters with serum levels of progesterone (P4) for the prediction of ovulation in infertile women. Methods Body mass index (BMI), cormic index (CI), waist‐hip ratio (WHR), waist‐height ratio (WHtR), neck circumference (NC) and triceps skinfold thickness (TSF) were measured for 60 anovulatory and ...
Akaninyene Eseme Ubom   +5 more
wiley   +1 more source

Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)

open access: yesArchives of Endocrinology and Metabolism
Hyperprolactinemia is a frequent cause of menstrual irregularity, galactorrhea, hypogonadism, and infertility. The most common etiologies of hyperprolactinemia can be classified as physiological, pharmacological, and pathological.
Andrea Glezer   +9 more
doaj   +1 more source

Subclinical cardiac alterations and cardiometabolic profile in adolescents with newly diagnosed polycystic ovary syndrome: A cross‐sectional comparative echocardiographic study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective While cardiometabolic comorbidities have been well established in adults with polycystic ovary syndrome (PCOS), it remains unclear whether the early signs of cardiovascular morbidity emerge during adolescence. This study aimed to investigate whether metabolic and cardiovascular alterations begin in adolescents with PCOS.
Demet Aygün Ari   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy